Through the use of nano-delivery technologies, the T cell activator anti-CD28-coupled aryl hydrocarbon receptor (AhR) inhibitor (CH223191) can be encapsulated to modify the tumor immune milieu and successfully prevent tumor cell metastasis (58). This evidence concerns the gene AHR and neoplasm.